Genetic Analysis Second Quarter 2025 Earnings: kr0.014 loss per share (vs kr0.11 loss in 2Q 2024)
Genetic Analysis (FRA:8V8) Second Quarter 2025 Results
Key Financial Results
- Revenue: kr7.15m (up 44% from 2Q 2024).
- Net loss: kr951.0k (loss narrowed by 80% from 2Q 2024).
- kr0.014 loss per share (improved from kr0.11 loss in 2Q 2024).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Genetic Analysis shares are up 17% from a week ago.
Risk Analysis
It’s necessary to consider the ever-present spectre of investment risk. We’ve identified 4 warning signs with Genetic Analysis (at least 2 which can’t be ignored), and understanding them should…
